Skip to content

Tenofovir DF

DRUG17 trials

Sponsors

National Cancer Institute (NCI), National Institute of Allergy and Infectious Diseases (NIAID), Gilead Sciences, Abbott, French National Agency for Research on AIDS and Viral Hepatitis

Conditions

Chronic Hepatitis BHBVHIV InfectionHIV InfectionsHIV SeronegativityHepatitis BLipodystrophyPregnancy

Phase 1

Phase 2

A Study to Compare Anti-HIV Drugs Given Twice a Day or Once a Day, With or Without Direct Observation
CompletedNCT00036452
National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections
End: 2006-01-31Updated: 2021-11-01
Effectiveness of ABT-378/Ritonavir Plus Lamivudine Plus Efavirenz Plus Tenofovir DF in HIV-Infected Patients
CompletedNCT00038220
AbbottHIV Infections
Start: 2000-07-31Target: 40Updated: 2006-07-27
Daily Tenofovir DF to Prevent HIV Infection Among Sex Workers in Cambodia
WithdrawnNCT00078182
National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections, HIV Seronegativity
Updated: 2016-12-14
Treatment of Persistent Viremia (Virus in Blood) in Chronic Hepatitis B Subjects Already Receiving Adefovir Dipivoxil
CompletedNCT00307489
Gilead SciencesChronic Hepatitis B
Start: 2006-03-31End: 2010-10-31Updated: 2011-11-01
A Study to Compare Tenofovir DF Versus the Combination of Emtricitabine Plus Tenofovir DF for the Treatment of Chronic Hepatitis B in Patients With Normal Alanine Aminotransferase (ALT)
CompletedNCT00507507
Gilead SciencesChronic Hepatitis B
Start: 2007-09-30End: 2012-08-31Updated: 2015-07-17
Study to Evaluate Changes in Limb Fat When Switching From a Thymidine Analogue
CompletedNCT00647946
Gilead SciencesLipodystrophy
Start: 2003-02-28End: 2006-02-28Updated: 2008-06-30
Rollover Protocol Continued Access to Tenofovir Disoproxil Fumarate (TDF) for Subjects in Taiwan
CompletedNCT01334567
Gilead SciencesHepatitis B
Start: 2010-08-31End: 2013-12-31Updated: 2014-03-04

Phase 3

Phase 4

Related Papers